SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                      the Securities Exchange Act of 1934

                        Date of Report: January 13, 2005
                        (Date of earliest event reported)

                               VASOMEDICAL, INC.
             (Exact name of registrant as specified in its charter)


    Delaware                      0-18105                       11-2871434 
(State or other                 (Commission                    (IRS Employer
 jurisdiction of                File Number)                   Identification
 incorporation)                                                   Number)


180 Linden Avenue, Westbury, New York                              11590      
(Address of principal executive offices)                        (Zip Code)



Registrant's telephone number including area code             (516) 997-4600


                                 Not applicable
                                 --------------
         (Former name or former address, if changed since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act

[ ] Pre-commencement  communications  pursuant to Rule 13e-4c under the Exchange
Act (17 CFR 240.13e-4c)





                    INFORMATION TO BE INCLUDED IN THE REPORT

     The  information in this Form 8-K Current  Report and the exhibit  attached
hereto is furnished  and shall not be deemed  "filed" for purposes of Section 18
of the  Securities  Exchange Act of 1934, as amended (the  "Exchange  Act"),  or
otherwise  subject to the  liabilities  of that Section,  nor shall it be deemed
incorporated  by reference in any filing of the Registrant  under the Securities
Act of 1933, as amended,  or the Exchange Act,  except as shall be expressly set
forth by specific reference in such filing.
 


Item 2.02       Results of Operations and Financial Condition

     On January 13, 2005,  Vasomedical,  Inc.  issued an earnings  press release
announcing its financial results for the second quarter ended November 30, 2004.
A copy of the earnings  press  release is attached as Exhibit 99 to this Current
Report on Form 8-K.

Item 9.01       Financial Statements and Exhibits

        (c)     Exhibits

               99   Earnings  Release,  dated January 13, 2005,  announcing  the
                    Registrant's  financial results for the second quarter ended
                    November 30, 2004.






                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities  Exchange Act of 1934, as
amended,  the  Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                                VASOMEDICAL, INC.

                                /s/Thomas W.  Fry
                                -----------------------------------
                                Thomas W.  Fry
                                Chief Financial Officer
                                (Principal Financial and Accounting
                                 Officer)


Dated:  January 18, 2005